Related Experiment Videos
Treatment of T prolymphocytic leukemia with allogeneic bone marrow transplantation
R H Collins1, L A Piñeiro, E D Agura
1Bone Marrow Transplantation, Baylor University Medical Center/Texas Oncology, Dallas 75246, USA.
Bone Marrow Transplantation
|May 15, 1998
Abstract:
T prolymphocytic leukemia (T-PLL) is an unusual disease characterized by high white cell counts, older age at presentation, splenomegaly and a very aggressive clinical course. We describe a 47-year-old male with refractory T-PLL who was treated with high-dose chemoradiotherapy and allogeneic bone marrow transplantation (BMT) from an HLA-matched sibling. The transplant was complicated by both acute and chronic graft-versus-host disease (GVHD). The patient achieved complete remission and remains in remission 3 years after the transplant.